Global Liposome Drug Delivery Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Liposome Drug Delivery market size is predicted to grow from US$ 4639 million in 2025 to US$ 9802 million in 2031; it is expected to grow at a CAGR of 13.3% from 2025 to 2031.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.
LP Information, Inc. (LPI) ' newest research report, the “Liposome Drug Delivery Industry Forecast” looks at past sales and reviews total world Liposome Drug Delivery sales in 2024, providing a comprehensive analysis by region and market sector of projected Liposome Drug Delivery sales for 2025 through 2031. With Liposome Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposome Drug Delivery industry.
This Insight Report provides a comprehensive analysis of the global Liposome Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposome Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liposome Drug Delivery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposome Drug Delivery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposome Drug Delivery.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposome Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Liposome Drug Delivery market?
What factors are driving Liposome Drug Delivery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liposome Drug Delivery market opportunities vary by end market size?
How does Liposome Drug Delivery break out by Type, by Application?
The global Liposome Drug Delivery market size is predicted to grow from US$ 4639 million in 2025 to US$ 9802 million in 2031; it is expected to grow at a CAGR of 13.3% from 2025 to 2031.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.
LP Information, Inc. (LPI) ' newest research report, the “Liposome Drug Delivery Industry Forecast” looks at past sales and reviews total world Liposome Drug Delivery sales in 2024, providing a comprehensive analysis by region and market sector of projected Liposome Drug Delivery sales for 2025 through 2031. With Liposome Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposome Drug Delivery industry.
This Insight Report provides a comprehensive analysis of the global Liposome Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposome Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liposome Drug Delivery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposome Drug Delivery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposome Drug Delivery.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposome Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Johnson & Johnson
- Luye Pharma
- Sigma-Tau
- Ipsen (Onivyde)
- CSPC
- Teva Pharmaceutical
- Novartis
- Fudan-Zhangjiang
What is the 10-year outlook for the global Liposome Drug Delivery market?
What factors are driving Liposome Drug Delivery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liposome Drug Delivery market opportunities vary by end market size?
How does Liposome Drug Delivery break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liposome Drug Delivery Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Liposome Drug Delivery by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Liposome Drug Delivery by Country/Region, 2020, 2024 & 2031
2.2 Liposome Drug Delivery Segment by Type
2.2.1 Liposomal Doxorubicin
2.2.2 Liposomal Amphoteracin B
2.2.3 Liposomal Paclitaxel
2.2.4 Others
2.3 Liposome Drug Delivery Sales by Type
2.3.1 Global Liposome Drug Delivery Sales Market Share by Type (2020-2025)
2.3.2 Global Liposome Drug Delivery Revenue and Market Share by Type (2020-2025)
2.3.3 Global Liposome Drug Delivery Sale Price by Type (2020-2025)
2.4 Liposome Drug Delivery Segment by Application
2.4.1 Fungal Infection Therapy
2.4.2 Cancer & Tumor Therapy
2.4.3 Others
2.5 Liposome Drug Delivery Sales by Application
2.5.1 Global Liposome Drug Delivery Sale Market Share by Application (2020-2025)
2.5.2 Global Liposome Drug Delivery Revenue and Market Share by Application (2020-2025)
2.5.3 Global Liposome Drug Delivery Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Liposome Drug Delivery Breakdown Data by Company
3.1.1 Global Liposome Drug Delivery Annual Sales by Company (2020-2025)
3.1.2 Global Liposome Drug Delivery Sales Market Share by Company (2020-2025)
3.2 Global Liposome Drug Delivery Annual Revenue by Company (2020-2025)
3.2.1 Global Liposome Drug Delivery Revenue by Company (2020-2025)
3.2.2 Global Liposome Drug Delivery Revenue Market Share by Company (2020-2025)
3.3 Global Liposome Drug Delivery Sale Price by Company
3.4 Key Manufacturers Liposome Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liposome Drug Delivery Product Location Distribution
3.4.2 Players Liposome Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIPOSOME DRUG DELIVERY BY GEOGRAPHIC REGION
4.1 World Historic Liposome Drug Delivery Market Size by Geographic Region (2020-2025)
4.1.1 Global Liposome Drug Delivery Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Liposome Drug Delivery Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Liposome Drug Delivery Market Size by Country/Region (2020-2025)
4.2.1 Global Liposome Drug Delivery Annual Sales by Country/Region (2020-2025)
4.2.2 Global Liposome Drug Delivery Annual Revenue by Country/Region (2020-2025)
4.3 Americas Liposome Drug Delivery Sales Growth
4.4 APAC Liposome Drug Delivery Sales Growth
4.5 Europe Liposome Drug Delivery Sales Growth
4.6 Middle East & Africa Liposome Drug Delivery Sales Growth
5 AMERICAS
5.1 Americas Liposome Drug Delivery Sales by Country
5.1.1 Americas Liposome Drug Delivery Sales by Country (2020-2025)
5.1.2 Americas Liposome Drug Delivery Revenue by Country (2020-2025)
5.2 Americas Liposome Drug Delivery Sales by Type (2020-2025)
5.3 Americas Liposome Drug Delivery Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposome Drug Delivery Sales by Region
6.1.1 APAC Liposome Drug Delivery Sales by Region (2020-2025)
6.1.2 APAC Liposome Drug Delivery Revenue by Region (2020-2025)
6.2 APAC Liposome Drug Delivery Sales by Type (2020-2025)
6.3 APAC Liposome Drug Delivery Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Liposome Drug Delivery by Country
7.1.1 Europe Liposome Drug Delivery Sales by Country (2020-2025)
7.1.2 Europe Liposome Drug Delivery Revenue by Country (2020-2025)
7.2 Europe Liposome Drug Delivery Sales by Type (2020-2025)
7.3 Europe Liposome Drug Delivery Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liposome Drug Delivery by Country
8.1.1 Middle East & Africa Liposome Drug Delivery Sales by Country (2020-2025)
8.1.2 Middle East & Africa Liposome Drug Delivery Revenue by Country (2020-2025)
8.2 Middle East & Africa Liposome Drug Delivery Sales by Type (2020-2025)
8.3 Middle East & Africa Liposome Drug Delivery Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposome Drug Delivery
10.3 Manufacturing Process Analysis of Liposome Drug Delivery
10.4 Industry Chain Structure of Liposome Drug Delivery
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liposome Drug Delivery Distributors
11.3 Liposome Drug Delivery Customer
12 WORLD FORECAST REVIEW FOR LIPOSOME DRUG DELIVERY BY GEOGRAPHIC REGION
12.1 Global Liposome Drug Delivery Market Size Forecast by Region
12.1.1 Global Liposome Drug Delivery Forecast by Region (2026-2031)
12.1.2 Global Liposome Drug Delivery Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Liposome Drug Delivery Forecast by Type (2026-2031)
12.7 Global Liposome Drug Delivery Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Liposome Drug Delivery Product Portfolios and Specifications
13.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 Pacira
13.2.1 Pacira Company Information
13.2.2 Pacira Liposome Drug Delivery Product Portfolios and Specifications
13.2.3 Pacira Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pacira Main Business Overview
13.2.5 Pacira Latest Developments
13.3 Sun Pharmaceutical
13.3.1 Sun Pharmaceutical Company Information
13.3.2 Sun Pharmaceutical Liposome Drug Delivery Product Portfolios and Specifications
13.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sun Pharmaceutical Main Business Overview
13.3.5 Sun Pharmaceutical Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Liposome Drug Delivery Product Portfolios and Specifications
13.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Luye Pharma
13.5.1 Luye Pharma Company Information
13.5.2 Luye Pharma Liposome Drug Delivery Product Portfolios and Specifications
13.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Luye Pharma Main Business Overview
13.5.5 Luye Pharma Latest Developments
13.6 Sigma-Tau
13.6.1 Sigma-Tau Company Information
13.6.2 Sigma-Tau Liposome Drug Delivery Product Portfolios and Specifications
13.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sigma-Tau Main Business Overview
13.6.5 Sigma-Tau Latest Developments
13.7 Ipsen (Onivyde)
13.7.1 Ipsen (Onivyde) Company Information
13.7.2 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolios and Specifications
13.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ipsen (Onivyde) Main Business Overview
13.7.5 Ipsen (Onivyde) Latest Developments
13.8 CSPC
13.8.1 CSPC Company Information
13.8.2 CSPC Liposome Drug Delivery Product Portfolios and Specifications
13.8.3 CSPC Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CSPC Main Business Overview
13.8.5 CSPC Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Liposome Drug Delivery Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Liposome Drug Delivery Product Portfolios and Specifications
13.10.3 Novartis Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Fudan-Zhangjiang
13.11.1 Fudan-Zhangjiang Company Information
13.11.2 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolios and Specifications
13.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Fudan-Zhangjiang Main Business Overview
13.11.5 Fudan-Zhangjiang Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Liposome Drug Delivery Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Liposome Drug Delivery Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liposomal Doxorubicin
Table 4. Major Players of Liposomal Amphoteracin B
Table 5. Major Players of Liposomal Paclitaxel
Table 6. Major Players of Others
Table 7. Global Liposome Drug Delivery Sales byType (2020-2025) & (K Vial)
Table 8. Global Liposome Drug Delivery Sales Market Share byType (2020-2025)
Table 9. Global Liposome Drug Delivery Revenue byType (2020-2025) & ($ million)
Table 10. Global Liposome Drug Delivery Revenue Market Share byType (2020-2025)
Table 11. Global Liposome Drug Delivery Sale Price byType (2020-2025) & (USD/Vial)
Table 12. Global Liposome Drug Delivery Sale by Application (2020-2025) & (K Vial)
Table 13. Global Liposome Drug Delivery Sale Market Share by Application (2020-2025)
Table 14. Global Liposome Drug Delivery Revenue by Application (2020-2025) & ($ million)
Table 15. Global Liposome Drug Delivery Revenue Market Share by Application (2020-2025)
Table 16. Global Liposome Drug Delivery Sale Price by Application (2020-2025) & (USD/Vial)
Table 17. Global Liposome Drug Delivery Sales by Company (2020-2025) & (K Vial)
Table 18. Global Liposome Drug Delivery Sales Market Share by Company (2020-2025)
Table 19. Global Liposome Drug Delivery Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Liposome Drug Delivery Revenue Market Share by Company (2020-2025)
Table 21. Global Liposome Drug Delivery Sale Price by Company (2020-2025) & (USD/Vial)
Table 22. Key Manufacturers Liposome Drug Delivery Producing Area Distribution and Sales Area
Table 23. Players Liposome Drug Delivery Products Offered
Table 24. Liposome Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Liposome Drug Delivery Sales by Geographic Region (2020-2025) & (K Vial)
Table 28. Global Liposome Drug Delivery Sales Market Share Geographic Region (2020-2025)
Table 29. Global Liposome Drug Delivery Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Liposome Drug Delivery Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Liposome Drug Delivery Sales by Country/Region (2020-2025) & (K Vial)
Table 32. Global Liposome Drug Delivery Sales Market Share by Country/Region (2020-2025)
Table 33. Global Liposome Drug Delivery Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Liposome Drug Delivery Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 36. Americas Liposome Drug Delivery Sales Market Share by Country (2020-2025)
Table 37. Americas Liposome Drug Delivery Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Liposome Drug Delivery Sales byType (2020-2025) & (K Vial)
Table 39. Americas Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 40. APAC Liposome Drug Delivery Sales by Region (2020-2025) & (K Vial)
Table 41. APAC Liposome Drug Delivery Sales Market Share by Region (2020-2025)
Table 42. APAC Liposome Drug Delivery Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Liposome Drug Delivery Sales byType (2020-2025) & (K Vial)
Table 44. APAC Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 45. Europe Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 46. Europe Liposome Drug Delivery Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Liposome Drug Delivery Sales byType (2020-2025) & (K Vial)
Table 48. Europe Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 49. Middle East & Africa Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 50. Middle East & Africa Liposome Drug Delivery Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Liposome Drug Delivery Sales byType (2020-2025) & (K Vial)
Table 52. Middle East & Africa Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 53. Key Market Drivers & Growth Opportunities of Liposome Drug Delivery
Table 54. Key Market Challenges & Risks of Liposome Drug Delivery
Table 55. Key IndustryTrends of Liposome Drug Delivery
Table 56. Liposome Drug Delivery Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Liposome Drug Delivery Distributors List
Table 59. Liposome Drug Delivery Customer List
Table 60. Global Liposome Drug Delivery SalesForecast by Region (2026-2031) & (K Vial)
Table 61. Global Liposome Drug Delivery RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Liposome Drug Delivery SalesForecast by Country (2026-2031) & (K Vial)
Table 63. Americas Liposome Drug Delivery Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Liposome Drug Delivery SalesForecast by Region (2026-2031) & (K Vial)
Table 65. APAC Liposome Drug Delivery Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Liposome Drug Delivery SalesForecast by Country (2026-2031) & (K Vial)
Table 67. Europe Liposome Drug Delivery RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Liposome Drug Delivery SalesForecast by Country (2026-2031) & (K Vial)
Table 69. Middle East & Africa Liposome Drug Delivery RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Liposome Drug Delivery SalesForecast byType (2026-2031) & (K Vial)
Table 71. Global Liposome Drug Delivery RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Liposome Drug Delivery SalesForecast by Application (2026-2031) & (K Vial)
Table 73. Global Liposome Drug Delivery RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Gilead Sciences Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 75. Gilead Sciences Liposome Drug Delivery Product Portfolios and Specifications
Table 76. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 77. Gilead Sciences Main Business
Table 78. Gilead Sciences Latest Developments
Table 79. Pacira Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 80. Pacira Liposome Drug Delivery Product Portfolios and Specifications
Table 81. Pacira Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 82. Pacira Main Business
Table 83. Pacira Latest Developments
Table 84. Sun Pharmaceutical Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 85. Sun Pharmaceutical Liposome Drug Delivery Product Portfolios and Specifications
Table 86. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 87. Sun Pharmaceutical Main Business
Table 88. Sun Pharmaceutical Latest Developments
Table 89. Johnson & Johnson Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 90. Johnson & Johnson Liposome Drug Delivery Product Portfolios and Specifications
Table 91. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 92. Johnson & Johnson Main Business
Table 93. Johnson & Johnson Latest Developments
Table 94. Luye Pharma Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 95. Luye Pharma Liposome Drug Delivery Product Portfolios and Specifications
Table 96. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 97. Luye Pharma Main Business
Table 98. Luye Pharma Latest Developments
Table 99. Sigma-Tau Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 100. Sigma-Tau Liposome Drug Delivery Product Portfolios and Specifications
Table 101. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 102. Sigma-Tau Main Business
Table 103. Sigma-Tau Latest Developments
Table 104. Ipsen (Onivyde) Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 105. Ipsen (Onivyde) Liposome Drug Delivery Product Portfolios and Specifications
Table 106. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 107. Ipsen (Onivyde) Main Business
Table 108. Ipsen (Onivyde) Latest Developments
Table 109. CSPC Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 110. CSPC Liposome Drug Delivery Product Portfolios and Specifications
Table 111. CSPC Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 112. CSPC Main Business
Table 113. CSPC Latest Developments
Table 114.Teva Pharmaceutical Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 115.Teva Pharmaceutical Liposome Drug Delivery Product Portfolios and Specifications
Table 116.Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 117.Teva Pharmaceutical Main Business
Table 118.Teva Pharmaceutical Latest Developments
Table 119. Novartis Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis Liposome Drug Delivery Product Portfolios and Specifications
Table 121. Novartis Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 122. Novartis Main Business
Table 123. Novartis Latest Developments
Table 124.Fudan-Zhangjiang Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 125.Fudan-Zhangjiang Liposome Drug Delivery Product Portfolios and Specifications
Table 126.Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 127.Fudan-Zhangjiang Main Business
Table 128.Fudan-Zhangjiang Latest Developments
LIST OFFIGURES
Figure 1. Picture of Liposome Drug Delivery
Figure 2. Liposome Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liposome Drug Delivery Sales Growth Rate 2020-2031 (K Vial)
Figure 7. Global Liposome Drug Delivery Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Liposome Drug Delivery Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Liposome Drug Delivery Sales Market Share by Country/Region (2024)
Figure 10. Liposome Drug Delivery Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liposomal Doxorubicin
Figure 12. Product Picture of Liposomal Amphoteracin B
Figure 13. Product Picture of Liposomal Paclitaxel
Figure 14. Product Picture of Others
Figure 15. Global Liposome Drug Delivery Sales Market Share byType in 2025
Figure 16. Global Liposome Drug Delivery Revenue Market Share byType (2020-2025)
Figure 17. Liposome Drug Delivery Consumed inFungal InfectionTherapy
Figure 18. Global Liposome Drug Delivery Market:Fungal InfectionTherapy (2020-2025) & (K Vial)
Figure 19. Liposome Drug Delivery Consumed in Cancer &TumorTherapy
Figure 20. Global Liposome Drug Delivery Market: Cancer &TumorTherapy (2020-2025) & (K Vial)
Figure 21. Liposome Drug Delivery Consumed in Others
Figure 22. Global Liposome Drug Delivery Market: Others (2020-2025) & (K Vial)
Figure 23. Global Liposome Drug Delivery Sale Market Share by Application (2024)
Figure 24. Global Liposome Drug Delivery Revenue Market Share by Application in 2025
Figure 25. Liposome Drug Delivery Sales by Company in 2025 (K Vial)
Figure 26. Global Liposome Drug Delivery Sales Market Share by Company in 2025
Figure 27. Liposome Drug Delivery Revenue by Company in 2025 ($ millions)
Figure 28. Global Liposome Drug Delivery Revenue Market Share by Company in 2025
Figure 29. Global Liposome Drug Delivery Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Liposome Drug Delivery Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Liposome Drug Delivery Sales 2020-2025 (K Vial)
Figure 32. Americas Liposome Drug Delivery Revenue 2020-2025 ($ millions)
Figure 33. APAC Liposome Drug Delivery Sales 2020-2025 (K Vial)
Figure 34. APAC Liposome Drug Delivery Revenue 2020-2025 ($ millions)
Figure 35. Europe Liposome Drug Delivery Sales 2020-2025 (K Vial)
Figure 36. Europe Liposome Drug Delivery Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Liposome Drug Delivery Sales 2020-2025 (K Vial)
Figure 38. Middle East & Africa Liposome Drug Delivery Revenue 2020-2025 ($ millions)
Figure 39. Americas Liposome Drug Delivery Sales Market Share by Country in 2025
Figure 40. Americas Liposome Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 41. Americas Liposome Drug Delivery Sales Market Share byType (2020-2025)
Figure 42. Americas Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 43. United States Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Liposome Drug Delivery Sales Market Share by Region in 2025
Figure 48. APAC Liposome Drug Delivery Revenue Market Share by Region (2020-2025)
Figure 49. APAC Liposome Drug Delivery Sales Market Share byType (2020-2025)
Figure 50. APAC Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 51. China Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 55. India Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Liposome Drug Delivery Sales Market Share by Country in 2025
Figure 59. Europe Liposome Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 60. Europe Liposome Drug Delivery Sales Market Share byType (2020-2025)
Figure 61. Europe Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 62. Germany Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 63.France Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Liposome Drug Delivery Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Liposome Drug Delivery Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 70. Egypt Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Liposome Drug Delivery in 2025
Figure 76. Manufacturing Process Analysis of Liposome Drug Delivery
Figure 77. Industry Chain Structure of Liposome Drug Delivery
Figure 78. Channels of Distribution
Figure 79. Global Liposome Drug Delivery Sales MarketForecast by Region (2026-2031)
Figure 80. Global Liposome Drug Delivery Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Liposome Drug Delivery Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Liposome Drug Delivery Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Liposome Drug Delivery Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Liposome Drug Delivery Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liposome Drug Delivery Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Liposome Drug Delivery by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Liposome Drug Delivery by Country/Region, 2020, 2024 & 2031
2.2 Liposome Drug Delivery Segment by Type
2.2.1 Liposomal Doxorubicin
2.2.2 Liposomal Amphoteracin B
2.2.3 Liposomal Paclitaxel
2.2.4 Others
2.3 Liposome Drug Delivery Sales by Type
2.3.1 Global Liposome Drug Delivery Sales Market Share by Type (2020-2025)
2.3.2 Global Liposome Drug Delivery Revenue and Market Share by Type (2020-2025)
2.3.3 Global Liposome Drug Delivery Sale Price by Type (2020-2025)
2.4 Liposome Drug Delivery Segment by Application
2.4.1 Fungal Infection Therapy
2.4.2 Cancer & Tumor Therapy
2.4.3 Others
2.5 Liposome Drug Delivery Sales by Application
2.5.1 Global Liposome Drug Delivery Sale Market Share by Application (2020-2025)
2.5.2 Global Liposome Drug Delivery Revenue and Market Share by Application (2020-2025)
2.5.3 Global Liposome Drug Delivery Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Liposome Drug Delivery Breakdown Data by Company
3.1.1 Global Liposome Drug Delivery Annual Sales by Company (2020-2025)
3.1.2 Global Liposome Drug Delivery Sales Market Share by Company (2020-2025)
3.2 Global Liposome Drug Delivery Annual Revenue by Company (2020-2025)
3.2.1 Global Liposome Drug Delivery Revenue by Company (2020-2025)
3.2.2 Global Liposome Drug Delivery Revenue Market Share by Company (2020-2025)
3.3 Global Liposome Drug Delivery Sale Price by Company
3.4 Key Manufacturers Liposome Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liposome Drug Delivery Product Location Distribution
3.4.2 Players Liposome Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIPOSOME DRUG DELIVERY BY GEOGRAPHIC REGION
4.1 World Historic Liposome Drug Delivery Market Size by Geographic Region (2020-2025)
4.1.1 Global Liposome Drug Delivery Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Liposome Drug Delivery Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Liposome Drug Delivery Market Size by Country/Region (2020-2025)
4.2.1 Global Liposome Drug Delivery Annual Sales by Country/Region (2020-2025)
4.2.2 Global Liposome Drug Delivery Annual Revenue by Country/Region (2020-2025)
4.3 Americas Liposome Drug Delivery Sales Growth
4.4 APAC Liposome Drug Delivery Sales Growth
4.5 Europe Liposome Drug Delivery Sales Growth
4.6 Middle East & Africa Liposome Drug Delivery Sales Growth
5 AMERICAS
5.1 Americas Liposome Drug Delivery Sales by Country
5.1.1 Americas Liposome Drug Delivery Sales by Country (2020-2025)
5.1.2 Americas Liposome Drug Delivery Revenue by Country (2020-2025)
5.2 Americas Liposome Drug Delivery Sales by Type (2020-2025)
5.3 Americas Liposome Drug Delivery Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposome Drug Delivery Sales by Region
6.1.1 APAC Liposome Drug Delivery Sales by Region (2020-2025)
6.1.2 APAC Liposome Drug Delivery Revenue by Region (2020-2025)
6.2 APAC Liposome Drug Delivery Sales by Type (2020-2025)
6.3 APAC Liposome Drug Delivery Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Liposome Drug Delivery by Country
7.1.1 Europe Liposome Drug Delivery Sales by Country (2020-2025)
7.1.2 Europe Liposome Drug Delivery Revenue by Country (2020-2025)
7.2 Europe Liposome Drug Delivery Sales by Type (2020-2025)
7.3 Europe Liposome Drug Delivery Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liposome Drug Delivery by Country
8.1.1 Middle East & Africa Liposome Drug Delivery Sales by Country (2020-2025)
8.1.2 Middle East & Africa Liposome Drug Delivery Revenue by Country (2020-2025)
8.2 Middle East & Africa Liposome Drug Delivery Sales by Type (2020-2025)
8.3 Middle East & Africa Liposome Drug Delivery Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposome Drug Delivery
10.3 Manufacturing Process Analysis of Liposome Drug Delivery
10.4 Industry Chain Structure of Liposome Drug Delivery
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liposome Drug Delivery Distributors
11.3 Liposome Drug Delivery Customer
12 WORLD FORECAST REVIEW FOR LIPOSOME DRUG DELIVERY BY GEOGRAPHIC REGION
12.1 Global Liposome Drug Delivery Market Size Forecast by Region
12.1.1 Global Liposome Drug Delivery Forecast by Region (2026-2031)
12.1.2 Global Liposome Drug Delivery Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Liposome Drug Delivery Forecast by Type (2026-2031)
12.7 Global Liposome Drug Delivery Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Liposome Drug Delivery Product Portfolios and Specifications
13.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 Pacira
13.2.1 Pacira Company Information
13.2.2 Pacira Liposome Drug Delivery Product Portfolios and Specifications
13.2.3 Pacira Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pacira Main Business Overview
13.2.5 Pacira Latest Developments
13.3 Sun Pharmaceutical
13.3.1 Sun Pharmaceutical Company Information
13.3.2 Sun Pharmaceutical Liposome Drug Delivery Product Portfolios and Specifications
13.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sun Pharmaceutical Main Business Overview
13.3.5 Sun Pharmaceutical Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Liposome Drug Delivery Product Portfolios and Specifications
13.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Luye Pharma
13.5.1 Luye Pharma Company Information
13.5.2 Luye Pharma Liposome Drug Delivery Product Portfolios and Specifications
13.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Luye Pharma Main Business Overview
13.5.5 Luye Pharma Latest Developments
13.6 Sigma-Tau
13.6.1 Sigma-Tau Company Information
13.6.2 Sigma-Tau Liposome Drug Delivery Product Portfolios and Specifications
13.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sigma-Tau Main Business Overview
13.6.5 Sigma-Tau Latest Developments
13.7 Ipsen (Onivyde)
13.7.1 Ipsen (Onivyde) Company Information
13.7.2 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolios and Specifications
13.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ipsen (Onivyde) Main Business Overview
13.7.5 Ipsen (Onivyde) Latest Developments
13.8 CSPC
13.8.1 CSPC Company Information
13.8.2 CSPC Liposome Drug Delivery Product Portfolios and Specifications
13.8.3 CSPC Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CSPC Main Business Overview
13.8.5 CSPC Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Liposome Drug Delivery Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Liposome Drug Delivery Product Portfolios and Specifications
13.10.3 Novartis Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Fudan-Zhangjiang
13.11.1 Fudan-Zhangjiang Company Information
13.11.2 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolios and Specifications
13.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Fudan-Zhangjiang Main Business Overview
13.11.5 Fudan-Zhangjiang Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Liposome Drug Delivery Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Liposome Drug Delivery Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liposomal Doxorubicin
Table 4. Major Players of Liposomal Amphoteracin B
Table 5. Major Players of Liposomal Paclitaxel
Table 6. Major Players of Others
Table 7. Global Liposome Drug Delivery Sales byType (2020-2025) & (K Vial)
Table 8. Global Liposome Drug Delivery Sales Market Share byType (2020-2025)
Table 9. Global Liposome Drug Delivery Revenue byType (2020-2025) & ($ million)
Table 10. Global Liposome Drug Delivery Revenue Market Share byType (2020-2025)
Table 11. Global Liposome Drug Delivery Sale Price byType (2020-2025) & (USD/Vial)
Table 12. Global Liposome Drug Delivery Sale by Application (2020-2025) & (K Vial)
Table 13. Global Liposome Drug Delivery Sale Market Share by Application (2020-2025)
Table 14. Global Liposome Drug Delivery Revenue by Application (2020-2025) & ($ million)
Table 15. Global Liposome Drug Delivery Revenue Market Share by Application (2020-2025)
Table 16. Global Liposome Drug Delivery Sale Price by Application (2020-2025) & (USD/Vial)
Table 17. Global Liposome Drug Delivery Sales by Company (2020-2025) & (K Vial)
Table 18. Global Liposome Drug Delivery Sales Market Share by Company (2020-2025)
Table 19. Global Liposome Drug Delivery Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Liposome Drug Delivery Revenue Market Share by Company (2020-2025)
Table 21. Global Liposome Drug Delivery Sale Price by Company (2020-2025) & (USD/Vial)
Table 22. Key Manufacturers Liposome Drug Delivery Producing Area Distribution and Sales Area
Table 23. Players Liposome Drug Delivery Products Offered
Table 24. Liposome Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Liposome Drug Delivery Sales by Geographic Region (2020-2025) & (K Vial)
Table 28. Global Liposome Drug Delivery Sales Market Share Geographic Region (2020-2025)
Table 29. Global Liposome Drug Delivery Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Liposome Drug Delivery Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Liposome Drug Delivery Sales by Country/Region (2020-2025) & (K Vial)
Table 32. Global Liposome Drug Delivery Sales Market Share by Country/Region (2020-2025)
Table 33. Global Liposome Drug Delivery Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Liposome Drug Delivery Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 36. Americas Liposome Drug Delivery Sales Market Share by Country (2020-2025)
Table 37. Americas Liposome Drug Delivery Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Liposome Drug Delivery Sales byType (2020-2025) & (K Vial)
Table 39. Americas Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 40. APAC Liposome Drug Delivery Sales by Region (2020-2025) & (K Vial)
Table 41. APAC Liposome Drug Delivery Sales Market Share by Region (2020-2025)
Table 42. APAC Liposome Drug Delivery Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Liposome Drug Delivery Sales byType (2020-2025) & (K Vial)
Table 44. APAC Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 45. Europe Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 46. Europe Liposome Drug Delivery Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Liposome Drug Delivery Sales byType (2020-2025) & (K Vial)
Table 48. Europe Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 49. Middle East & Africa Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
Table 50. Middle East & Africa Liposome Drug Delivery Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Liposome Drug Delivery Sales byType (2020-2025) & (K Vial)
Table 52. Middle East & Africa Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
Table 53. Key Market Drivers & Growth Opportunities of Liposome Drug Delivery
Table 54. Key Market Challenges & Risks of Liposome Drug Delivery
Table 55. Key IndustryTrends of Liposome Drug Delivery
Table 56. Liposome Drug Delivery Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Liposome Drug Delivery Distributors List
Table 59. Liposome Drug Delivery Customer List
Table 60. Global Liposome Drug Delivery SalesForecast by Region (2026-2031) & (K Vial)
Table 61. Global Liposome Drug Delivery RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Liposome Drug Delivery SalesForecast by Country (2026-2031) & (K Vial)
Table 63. Americas Liposome Drug Delivery Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Liposome Drug Delivery SalesForecast by Region (2026-2031) & (K Vial)
Table 65. APAC Liposome Drug Delivery Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Liposome Drug Delivery SalesForecast by Country (2026-2031) & (K Vial)
Table 67. Europe Liposome Drug Delivery RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Liposome Drug Delivery SalesForecast by Country (2026-2031) & (K Vial)
Table 69. Middle East & Africa Liposome Drug Delivery RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Liposome Drug Delivery SalesForecast byType (2026-2031) & (K Vial)
Table 71. Global Liposome Drug Delivery RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Liposome Drug Delivery SalesForecast by Application (2026-2031) & (K Vial)
Table 73. Global Liposome Drug Delivery RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Gilead Sciences Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 75. Gilead Sciences Liposome Drug Delivery Product Portfolios and Specifications
Table 76. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 77. Gilead Sciences Main Business
Table 78. Gilead Sciences Latest Developments
Table 79. Pacira Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 80. Pacira Liposome Drug Delivery Product Portfolios and Specifications
Table 81. Pacira Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 82. Pacira Main Business
Table 83. Pacira Latest Developments
Table 84. Sun Pharmaceutical Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 85. Sun Pharmaceutical Liposome Drug Delivery Product Portfolios and Specifications
Table 86. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 87. Sun Pharmaceutical Main Business
Table 88. Sun Pharmaceutical Latest Developments
Table 89. Johnson & Johnson Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 90. Johnson & Johnson Liposome Drug Delivery Product Portfolios and Specifications
Table 91. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 92. Johnson & Johnson Main Business
Table 93. Johnson & Johnson Latest Developments
Table 94. Luye Pharma Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 95. Luye Pharma Liposome Drug Delivery Product Portfolios and Specifications
Table 96. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 97. Luye Pharma Main Business
Table 98. Luye Pharma Latest Developments
Table 99. Sigma-Tau Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 100. Sigma-Tau Liposome Drug Delivery Product Portfolios and Specifications
Table 101. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 102. Sigma-Tau Main Business
Table 103. Sigma-Tau Latest Developments
Table 104. Ipsen (Onivyde) Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 105. Ipsen (Onivyde) Liposome Drug Delivery Product Portfolios and Specifications
Table 106. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 107. Ipsen (Onivyde) Main Business
Table 108. Ipsen (Onivyde) Latest Developments
Table 109. CSPC Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 110. CSPC Liposome Drug Delivery Product Portfolios and Specifications
Table 111. CSPC Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 112. CSPC Main Business
Table 113. CSPC Latest Developments
Table 114.Teva Pharmaceutical Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 115.Teva Pharmaceutical Liposome Drug Delivery Product Portfolios and Specifications
Table 116.Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 117.Teva Pharmaceutical Main Business
Table 118.Teva Pharmaceutical Latest Developments
Table 119. Novartis Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis Liposome Drug Delivery Product Portfolios and Specifications
Table 121. Novartis Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 122. Novartis Main Business
Table 123. Novartis Latest Developments
Table 124.Fudan-Zhangjiang Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 125.Fudan-Zhangjiang Liposome Drug Delivery Product Portfolios and Specifications
Table 126.Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 127.Fudan-Zhangjiang Main Business
Table 128.Fudan-Zhangjiang Latest Developments
LIST OFFIGURES
Figure 1. Picture of Liposome Drug Delivery
Figure 2. Liposome Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liposome Drug Delivery Sales Growth Rate 2020-2031 (K Vial)
Figure 7. Global Liposome Drug Delivery Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Liposome Drug Delivery Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Liposome Drug Delivery Sales Market Share by Country/Region (2024)
Figure 10. Liposome Drug Delivery Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liposomal Doxorubicin
Figure 12. Product Picture of Liposomal Amphoteracin B
Figure 13. Product Picture of Liposomal Paclitaxel
Figure 14. Product Picture of Others
Figure 15. Global Liposome Drug Delivery Sales Market Share byType in 2025
Figure 16. Global Liposome Drug Delivery Revenue Market Share byType (2020-2025)
Figure 17. Liposome Drug Delivery Consumed inFungal InfectionTherapy
Figure 18. Global Liposome Drug Delivery Market:Fungal InfectionTherapy (2020-2025) & (K Vial)
Figure 19. Liposome Drug Delivery Consumed in Cancer &TumorTherapy
Figure 20. Global Liposome Drug Delivery Market: Cancer &TumorTherapy (2020-2025) & (K Vial)
Figure 21. Liposome Drug Delivery Consumed in Others
Figure 22. Global Liposome Drug Delivery Market: Others (2020-2025) & (K Vial)
Figure 23. Global Liposome Drug Delivery Sale Market Share by Application (2024)
Figure 24. Global Liposome Drug Delivery Revenue Market Share by Application in 2025
Figure 25. Liposome Drug Delivery Sales by Company in 2025 (K Vial)
Figure 26. Global Liposome Drug Delivery Sales Market Share by Company in 2025
Figure 27. Liposome Drug Delivery Revenue by Company in 2025 ($ millions)
Figure 28. Global Liposome Drug Delivery Revenue Market Share by Company in 2025
Figure 29. Global Liposome Drug Delivery Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Liposome Drug Delivery Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Liposome Drug Delivery Sales 2020-2025 (K Vial)
Figure 32. Americas Liposome Drug Delivery Revenue 2020-2025 ($ millions)
Figure 33. APAC Liposome Drug Delivery Sales 2020-2025 (K Vial)
Figure 34. APAC Liposome Drug Delivery Revenue 2020-2025 ($ millions)
Figure 35. Europe Liposome Drug Delivery Sales 2020-2025 (K Vial)
Figure 36. Europe Liposome Drug Delivery Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Liposome Drug Delivery Sales 2020-2025 (K Vial)
Figure 38. Middle East & Africa Liposome Drug Delivery Revenue 2020-2025 ($ millions)
Figure 39. Americas Liposome Drug Delivery Sales Market Share by Country in 2025
Figure 40. Americas Liposome Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 41. Americas Liposome Drug Delivery Sales Market Share byType (2020-2025)
Figure 42. Americas Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 43. United States Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Liposome Drug Delivery Sales Market Share by Region in 2025
Figure 48. APAC Liposome Drug Delivery Revenue Market Share by Region (2020-2025)
Figure 49. APAC Liposome Drug Delivery Sales Market Share byType (2020-2025)
Figure 50. APAC Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 51. China Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 55. India Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Liposome Drug Delivery Sales Market Share by Country in 2025
Figure 59. Europe Liposome Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 60. Europe Liposome Drug Delivery Sales Market Share byType (2020-2025)
Figure 61. Europe Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 62. Germany Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 63.France Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Liposome Drug Delivery Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Liposome Drug Delivery Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Liposome Drug Delivery Sales Market Share by Application (2020-2025)
Figure 70. Egypt Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Liposome Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Liposome Drug Delivery in 2025
Figure 76. Manufacturing Process Analysis of Liposome Drug Delivery
Figure 77. Industry Chain Structure of Liposome Drug Delivery
Figure 78. Channels of Distribution
Figure 79. Global Liposome Drug Delivery Sales MarketForecast by Region (2026-2031)
Figure 80. Global Liposome Drug Delivery Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Liposome Drug Delivery Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Liposome Drug Delivery Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Liposome Drug Delivery Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Liposome Drug Delivery Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Direct-to-consumer Disease Risk and Health Test Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
151 pages
Global Decitabine Drug Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
December 2025
91 pages
Global Valsartan-Hydrochlorothiazide Market Growth 2025-2031
US$ 3,660.00
October 2025
122 pages
Global Scleroderma Therapeutics Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
123 pages
